Intermediate-type vancomycin resistance (VISA) in genetically-distinct Staphylococcus aureus isolates is linked to specific, reversible metabolic alterations.
Intermediate (VISA-type) vancomycin resistance in Staphylococcus aureus has been associated with a range of physiologic and genetic alterations. Previous work described the emergence of VISA-type resistance in two clonally-distinct series of isolates. In both series (the first belonging to MRSA clon...
Main Authors: | Elizabeth L Alexander, Susana Gardete, Haim Y Bar, Martin T Wells, Alexander Tomasz, Kyu Y Rhee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4016254?pdf=render |
Similar Items
-
Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)
by: Michelle Su, et al.
Published: (2021-07-01) -
Vancomycin intermediate-Resistant Staphylococcus aureus (VISA) Isolated from a patient who never received Vancomycin treatment
by: Xuhui Zhu, et al.
Published: (2015-04-01) -
Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in prosthetic joint infections: a case series and review
by: Chaudhuri A, et al.
Published: (2012-05-01) -
Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus
by: Qiwen Hu, et al.
Published: (2016-10-01) -
Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
by: Liang J, et al.
Published: (2023-01-01)